How India Built the World's Most Aggressive Patent Wall and Became the Pharmacy of the Global South
From Process Patents to Compulsory Licensing – A Nation's Fight for Affordable Medicine Between 1970 and 2026, India transformed from a colonial-era patent follower into the world's most aggressive defender of affordable medicine. Through a trilogy of legal innovations—process patents, Section 3(d)'s anti-evergreening provisions, and compulsory licensing—India built what experts call the "hard stop" at twenty years of patent protection, compared to thirty to forty years in the West. Yet this pharmaceutical sovereignty comes with a paradox: while India supplies sixty percent of the world's vaccines and forty percent of America's generic drugs, it remains ninety to one hundred percent dependent on China for the raw ingredients of basic antibiotics. This article examines the legal battles, the trade-offs, and the emerging counter-offensive as India navigates between public health and geopolitical vulnerability. Part One: The Accidental Empire – Ho...